Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex K Bryant

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 4, 2022
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung CancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2022
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant DurvalumabAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 27, 2021
Prostate radiotherapy in the setting of bilateral hip prostheses: All commonly used photon-based radiation approaches are feasibleMatthew M Cousins, Eric Short, Paul Heckman, et al.
Plos One|January 17, 2020
Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated toolsKathleen M Akgün, Keith Sigel, Kei-Hoi Cheung, et al.
BJU International|April 4, 2022
Development and validation of a life expectancy calculator for US patients with prostate cancerElizabeth C Chase, Alex K Bryant, Yilun Sun, et al.
World Neurosurgery|September 30, 2018
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results DatabaseAli A Alattar, Kate T Carroll, Alex K Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2019
A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation TherapyRoss Mudgway, Alex K Bryant, Elena S Heide, et al.
Journal for Immunotherapy of Cancer|June 23, 2026
Heterogeneous survival impact of immune-related adverse events in US veteransSadiq Rehmani, Luke Michael Higgins, Daria Brinzevich, et al.
Cancer|February 13, 2019
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapyRishi Deka, Brent S Rose, Alex K Bryant, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|February 4, 2022
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung CancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2022
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant DurvalumabAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 27, 2021
Prostate radiotherapy in the setting of bilateral hip prostheses: All commonly used photon-based radiation approaches are feasibleMatthew M Cousins, Eric Short, Paul Heckman, et al.
Plos One|January 17, 2020
Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated toolsKathleen M Akgün, Keith Sigel, Kei-Hoi Cheung, et al.
BJU International|April 4, 2022
Development and validation of a life expectancy calculator for US patients with prostate cancerElizabeth C Chase, Alex K Bryant, Yilun Sun, et al.
World Neurosurgery|September 30, 2018
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results DatabaseAli A Alattar, Kate T Carroll, Alex K Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2019
A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation TherapyRoss Mudgway, Alex K Bryant, Elena S Heide, et al.
Journal for Immunotherapy of Cancer|June 23, 2026
Heterogeneous survival impact of immune-related adverse events in US veteransSadiq Rehmani, Luke Michael Higgins, Daria Brinzevich, et al.
Cancer|February 13, 2019
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapyRishi Deka, Brent S Rose, Alex K Bryant, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Pageof 8